EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints

Banty Kumar, Ankur Vaidya iD, Shweta Jain iD, Sanjeev Kumar Sahu iD, Preeti Patel iD, Vivek Asati iD

ChemMedChem · 28.10.2026 · 21 (20)

DOI: 10.1002/cmdc.70533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 14.10.2026. Verfasst von Banty Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah, U.P., India. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Antineoplastic Agents, Signal Transduction, Protein Kinase Inhibitors. Die Arbeit nennt 101 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pim‐1, a carcinogenic threonine and serine kinase, inhibits apoptosis and advances the cell cycle. It is overexpressed in several human cancers. The proviral integration site of Moloney murine leukemia virus 1 is Pim‐1. Previous studies have shown that the Pim‐1 30‐UTR regulates the stability of Pim‐1 mRNA. Threonine and serine are identified as the proto‐oncogene Pim‐1 kinase. Pim‐1 mediates numerous biological processes, including apoptosis, cell division, proliferation, and cancer. Pim‐1‐mediated anticancer activity has been reported in several analogs of thiazole/ bis ‐thiazole, tetrazine, thiophenes, quinoline, pyrazolopyrimidine, 3‐cyanopyridine, thiazolidine‐2,4‐dione, thieno[2,3‐ b ]pyridine, triazolo[4,3‐ b ]pyridazine, pyrazolo[1,5‐ a ]pyrimidines, and pyrazolo[3,4‐ b ]pyridine derivatives. Additionally, flavonoids and amino alcohol compounds that constitute Pim‐1‐mediated cancer therapy have also been identified thus far. Many compounds with Pim‐1‐mediated cytotoxicity have been discovered up to this point, and scientists are currently concentrating on bringing novel compounds with anticancer potential to the market.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-pim-1Antineoplastic AgentsSignal TransductionProtein Kinase InhibitorsNeoplasmsHumansProto-Oncogene MasAnimalsApoptosisStructure-Activity Relationship

Stichwörter der Autor:innen

Pim‐1amino alcoholapoptosiscancerflavonoidquinoline

Substanzen

Proto-Oncogene Proteins c-pim-1Antineoplastic AgentsProto-Oncogene MasMAS1 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah, U.P., India.
  • Sir Madanlal Institute of Pharmacy, Etawah, U.P., India.
  • School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Punjab, India.
  • Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.

ORCID-Profile: Ankur Vaidya, Shweta Jain, Sanjeev Kumar Sahu, Preeti Patel, Vivek Asati

Zitieren

APA

Kumar, B., Vaidya, A., Jain, S., Sahu, S. K., Patel, P., & Asati, V. (2026). Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70533

Vancouver

Kumar B, Vaidya A, Jain S, Sahu SK, Patel P, Asati V. Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70533

BibTeX
@article{Kumar2026,
  author = {Kumar, Banty and Vaidya, Ankur and Jain, Shweta and Sahu, Sanjeev Kumar and Patel, Preeti and Asati, Vivek},
  title = {Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70533}
}
Kostenlos starten →